WENR ANNOUNCES LETTER OF INTENT WITH ST. PAUL PHARMACEUTICAL

WENR Corp. (OTC:WNRC) (wenr.net), announced today that it has signed a letter of intent to merge with St. Paul Pharmaceutical, a Puerto Rican based company. The parties anticipate closing within 90 days. Terms were not disclosed. St. Paul Pharmaceutical, Inc., is incorporated in Puerto Rico and authorized to do business in California. It has operations in Garden Grove, California, Vancouver, British Columbia and also Viet Nam. St. Paul is a pharmaceutical company that specializes in the manufacture and distribution of generic pharmaceuticals, generic over-the-counter pharmaceuticals and vitamin supplements.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050810005281&newsLang=en)